Research Article
Use of PEGylated Recombinant Human Growth Hormone in Chinese Children with Growth Hormone Deficiency: A 24-Month Follow-Up Study
Table 1
Demographic and baseline characteristics.
| Characteristics | Group | PEGylated rhGH | Daily rhGH | value |
| Number of patients (n) | 49 | 49 | | Male | 26 | 33 | | Female | 23 | 16 | | Chronological age (yrs) | 5.41 ± 2.37 | 6.25 ± 2.42 | 0.373 | Bone age (yrs) | 4.47 ± 2.29 | 4.37 ± 2.47 | 0.237 | BA/CA | 0.66 ± 0.26 | 0.69 ± 0.29 | 0.198 | Previous height velocity (cm/yr) | 3.78 ± 0.78 | 3.36 ± 1.00 | 0.091 | Height SDS | −2.57 ± 0.75 | −2.50 ± 0.59 | 0.490 | Parental height (cm) | Father height | 169 ± 5.40 | 169 ± 5.21 | 0.674 | Mother height | 158 ± 4.90 | 156 ± 4.42 | 0.851 | BMI (kg/m2) | 15.27 ± 1.45 | 15.13 ± 1.00 | 0.417 | IGF-1 SDS | −1.28 ± 0.98 | −1.24 ± 0.99 | 0.750 | Peak GH (ng/ml) | 5.91 ± 2.34 | 6.21 ± 2.02 | 0.202 | Height of hypophysis (mm) | 3.58 ± 0.74 | 3.89 ± 1.14 | 0.340 |
|
|
Data is represented as mean ± SD.
|